{"entity":{"type":"insider","cik":"0001798117","url":"/insider/0001798117","json_url":"/insider/0001798117.json","name":"Norry Elliot","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":14,"first":"2020-01-15","last":"2025-01-17","span_basis":"filed_date"},"name_variants":[{"name":"Norry Elliot","source":"filing","n_filings":14,"first_seen":"2020-01-15","last_seen":"2025-01-17"}],"transactions":[{"id":4547599,"accession":"0001104659-25-004608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-004608","line_url":"/filing/0001104659-25-004608#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5584.0,"shares_display":"5,584","price_per_share":0.5808,"price_display":"0.58","price_state":"stated","total_value":3243.1872,"total_display":"3,243.19","total_whole":"3,243","shares_owned_after":7510.0,"shares_owned_after_display":"7,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-17","scope":"insider"},{"id":5206071,"accession":"0001104659-25-003771","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-003771","line_url":"/filing/0001104659-25-003771#line-3","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9803.0,"shares_display":"9,803","price_per_share":0.5748,"price_display":"0.57","price_state":"stated","total_value":5634.7644,"total_display":"5,634.76","total_whole":"5,635","shares_owned_after":13756.0,"shares_owned_after_display":"13,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-15","scope":"insider"},{"id":5206066,"accession":"0001104659-25-003771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-003771","line_url":"/filing/0001104659-25-003771","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12392.0,"shares_display":"12,392","price_per_share":0.5879,"price_display":"0.59","price_state":"stated","total_value":7285.2568,"total_display":"7,285.26","total_whole":"7,285","shares_owned_after":11516.0,"shares_owned_after_display":"11,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider","n_lines":2},{"id":2555186,"accession":"0001104659-24-004563","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-004563","line_url":"/filing/0001104659-24-004563","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18276.0,"shares_display":"18,276","price_per_share":0.673,"price_display":"0.67","price_state":"stated","total_value":12299.748,"total_display":"12,299.75","total_whole":"12,300","shares_owned_after":19257.0,"shares_owned_after_display":"19,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-17","scope":"insider","n_lines":2},{"id":2555178,"accession":"0001104659-24-004563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-004563","line_url":"/filing/0001104659-24-004563#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2287.0,"shares_display":"2,287","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":1806.73,"total_display":"1,806.73","total_whole":"1,807","shares_owned_after":3363.0,"shares_owned_after_display":"3,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":2042960,"accession":"0001104659-24-003743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-003743","line_url":"/filing/0001104659-24-003743#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7799.0,"shares_display":"7,799","price_per_share":0.8541,"price_display":"0.85","price_state":"stated","total_value":6661.1259,"total_display":"6,661.13","total_whole":"6,661","shares_owned_after":11841.0,"shares_owned_after_display":"11,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-12","scope":"insider"},{"id":2042959,"accession":"0001104659-24-003743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-003743","line_url":"/filing/0001104659-24-003743#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4009.0,"shares_display":"4,009","price_per_share":0.8367,"price_display":"0.84","price_state":"stated","total_value":3354.3303,"total_display":"3,354.33","total_whole":"3,354","shares_owned_after":6104.0,"shares_owned_after_display":"6,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider"},{"id":8586044,"accession":"0001104659-23-004380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-004380","line_url":"/filing/0001104659-23-004380#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2159.0,"shares_display":"2,159","price_per_share":1.858,"price_display":"1.86","price_state":"stated","total_value":4011.422,"total_display":"4,011.42","total_whole":"4,011","shares_owned_after":3491.0,"shares_owned_after_display":"3,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-17","scope":"insider"},{"id":7921688,"accession":"0001104659-23-003535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-003535","line_url":"/filing/0001104659-23-003535#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7449.0,"shares_display":"7,449","price_per_share":1.706,"price_display":"1.71","price_state":"stated","total_value":12707.994,"total_display":"12,707.99","total_whole":"12,708","shares_owned_after":12191.0,"shares_owned_after_display":"12,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-12","scope":"insider"},{"id":7921685,"accession":"0001104659-23-003535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-003535","line_url":"/filing/0001104659-23-003535#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3843.0,"shares_display":"3,843","price_per_share":1.7468,"price_display":"1.75","price_state":"stated","total_value":6712.9524,"total_display":"6,712.95","total_whole":"6,713","shares_owned_after":6270.0,"shares_owned_after_display":"6,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":7840828,"accession":"0001104659-23-001089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-001089","line_url":"/filing/0001104659-23-001089#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":876.0,"shares_display":"876","price_per_share":1.694,"price_display":"1.69","price_state":"stated","total_value":1483.944,"total_display":"1,483.94","total_whole":"1,484","shares_owned_after":1361.0,"shares_owned_after_display":"1,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":6680084,"accession":"0001104659-22-005054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-005054","line_url":"/filing/0001104659-22-005054#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2121.0,"shares_display":"2,121","price_per_share":3.1918,"price_display":"3.19","price_state":"stated","total_value":6769.8078,"total_display":"6,769.81","total_whole":"6,770","shares_owned_after":3529.0,"shares_owned_after_display":"3,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6568805,"accession":"0001104659-22-004150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-004150","line_url":"/filing/0001104659-22-004150#line-2","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":854.0,"shares_display":"854","price_per_share":3.5441,"price_display":"3.54","price_state":"stated","total_value":3026.6614,"total_display":"3,026.66","total_whole":"3,027","shares_owned_after":1383.0,"shares_owned_after_display":"1,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-12","filed_date":"2022-01-13","scope":"insider"},{"id":6568801,"accession":"0001104659-22-004150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-004150","line_url":"/filing/0001104659-22-004150#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3770.0,"shares_display":"3,770","price_per_share":3.5567,"price_display":"3.56","price_state":"stated","total_value":13408.759,"total_display":"13,408.76","total_whole":"13,409","shares_owned_after":6343.0,"shares_owned_after_display":"6,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":6990286,"accession":"0001104659-22-001669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-001669","line_url":"/filing/0001104659-22-001669#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":849.0,"shares_display":"849","price_per_share":4.0642,"price_display":"4.06","price_state":"stated","total_value":3450.5058,"total_display":"3,450.51","total_whole":"3,451","shares_owned_after":1388.0,"shares_owned_after_display":"1,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4365041,"accession":"0001104659-21-005546","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-005546","line_url":"/filing/0001104659-21-005546#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2111.0,"shares_display":"2,111","price_per_share":5.6695,"price_display":"5.67","price_state":"stated","total_value":11968.3145,"total_display":"11,968.31","total_whole":"11,968","shares_owned_after":3539.0,"shares_owned_after_display":"3,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider"},{"id":5403622,"accession":"0001104659-21-003591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-003591","line_url":"/filing/0001104659-21-003591#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":841.0,"shares_display":"841","price_per_share":6.1522,"price_display":"6.15","price_state":"stated","total_value":5174.0002,"total_display":"5,174.00","total_whole":"5,174","shares_owned_after":1396.0,"shares_owned_after_display":"1,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-12","scope":"insider"},{"id":4281290,"accession":"0001104659-21-001176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-001176","line_url":"/filing/0001104659-21-001176#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":845.0,"shares_display":"845","price_per_share":5.3279,"price_display":"5.33","price_state":"stated","total_value":4502.0755,"total_display":"4,502.08","total_whole":"4,502","shares_owned_after":1392.0,"shares_owned_after_display":"1,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":3079767,"accession":"0001104659-20-004424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-004424","line_url":"/filing/0001104659-20-004424#line-1","is_derivative":false,"issuer_cik":"0001621227","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001621227","owner_cik":"0001798117","owner_name":"Norry Elliot","owner_display_name":"Norry Elliot","owner_url":"/insider/0001798117","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":5.1347,"price_display":"5.13","price_state":"stated","total_value":4677.7117,"total_display":"4,677.71","total_whole":"4,678","shares_owned_after":1326.0,"shares_owned_after_display":"1,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-14","filed_date":"2020-01-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Officer (Chief Medical Officer)","n_filings":14,"first_seen":"2020-01-15","last_seen":"2025-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001798117","retrieved_at":"2026-08-22T13:05:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}